Consistently, the number of Ki-67 positive (proliferating) RA FLS was decreased by VP treatment in the presence of TNF and IL-17 assessed by two independent methods: immunofluorescence (Figures 3D, E) or flow cytometry (Figure 3F). This evidence concerns the gene MKI67 and rheumatoid arthritis.